The future of molecular genetic testing.
暂无分享,去创建一个
[1] D. Seligson,et al. Clinical Chemistry , 1965, Bulletin de la Societe de chimie biologique.
[2] C. Cantor,et al. A strategy for rapid and efficient DNA sequencing by mass spectrometry , 1996, Nature Biotechnology.
[3] E. Kmiec,et al. Targeted gene correction: a new strategy for molecular medicine. , 1998, Molecular medicine today.
[4] R. Munford,et al. Physiologically responsive gene therapy. , 1998, Molecular medicine today.
[5] J. Hodgson,et al. DNA chips: An array of possibilities , 1998, Nature Biotechnology.
[6] A. Persidis. Pharmacogenomics and diagnostics , 1998, Nature Biotechnology.
[7] David Housman,et al. Why pharmacogenomics? Why now? , 1998, Nature Biotechnology.
[8] G. Ramsay. DNA chips: State-of-the art , 1998, Nature Biotechnology.
[9] F. Collins,et al. New goals for the U.S. Human Genome Project: 1998-2003. , 1998, Science.
[10] W. Evans,et al. Pharmacogenetics of cancer therapy: getting personal. , 1998, American journal of human genetics.
[11] E. Boerwinkle,et al. DNA sequence diversity in a 9.7-kb region of the human lipoprotein lipase gene , 1998, Nature Genetics.
[12] Charles R. Cantor,et al. Sequencing exons 5 to 8 of the p53 gene by MALDI-TOF mass spectrometry , 1998, Nature Biotechnology.
[13] W. KALOWa. Pharmacogenetics in Biological Perspective , 1998 .